Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Post-marketing Drug Intensive Monitoring Study of Compound Sodium Picosulfate Granules for Bowel Preparation in Chinese Population

NCT04852120 is registered in ClinicalTrials.gov with Ferring Pharmaceuticals as lead sponsor.

NCT NCT04852120
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04852120 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Post-marketing Drug Intensive Monitoring Study of Compound Sodium Picosulfate Granules for Bowel Preparation in Chinese Population
Lead sponsor
Ferring Pharmaceuticals
Phase
Observational
Overall status
Completed
Start date
April 1, 2021
Completion date
December 31, 2022
Enrollment
3,000 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

bowel cleansing